Daniel Burch

1.0k total citations
12 papers, 796 citations indexed

About

Daniel Burch is a scholar working on Epidemiology, Pharmacology and Otorhinolaryngology. According to data from OpenAlex, Daniel Burch has authored 12 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Pharmacology and 3 papers in Otorhinolaryngology. Recurrent topics in Daniel Burch's work include Pneumonia and Respiratory Infections (5 papers), Ear Surgery and Otitis Media (3 papers) and Respiratory and Cough-Related Research (2 papers). Daniel Burch is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Ear Surgery and Otitis Media (3 papers) and Respiratory and Cough-Related Research (2 papers). Daniel Burch collaborates with scholars based in United States, United Kingdom and Israel. Daniel Burch's co-authors include Ron Dagan, Michael R. Jacobs, Peter C. Appelbaum, Carolyn E. Behrendt, Michael D. Decker, Jack L. Paradise, Alejandro Hoberman, James Hedrick, Jesús M Feris and Nazha Abughali and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Tetrahedron Letters and The Pediatric Infectious Disease Journal.

In The Last Decade

Daniel Burch

12 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Burch United States 9 550 328 226 160 128 12 796
Jean‐Marie Goehrs France 8 163 0.3× 173 0.5× 79 0.3× 52 0.3× 51 0.4× 14 448
P Grob United Kingdom 10 185 0.3× 246 0.8× 242 1.1× 99 0.6× 21 0.2× 27 637
P Davey United Kingdom 9 173 0.3× 84 0.3× 53 0.2× 29 0.2× 45 0.4× 19 601
M. Maya Dutta-Linn United States 11 368 0.7× 83 0.3× 23 0.1× 109 0.7× 30 0.2× 14 597
Andrew Coco United States 11 131 0.2× 101 0.3× 79 0.3× 26 0.2× 22 0.2× 16 459
Bryan Knepper United States 18 244 0.4× 55 0.2× 30 0.1× 21 0.1× 68 0.5× 60 861
Jennifer E Girotto United States 12 143 0.3× 65 0.2× 21 0.1× 10 0.1× 123 1.0× 35 372
Laurence Caeymaex France 15 101 0.2× 286 0.9× 17 0.1× 43 0.3× 14 0.1× 50 706
Sophie E. Katz United States 12 183 0.3× 108 0.3× 14 0.1× 14 0.1× 29 0.2× 42 428
Viola Korczak Australia 9 422 0.8× 96 0.3× 12 0.1× 344 2.1× 17 0.1× 14 740

Countries citing papers authored by Daniel Burch

Since Specialization
Citations

This map shows the geographic impact of Daniel Burch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Burch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Burch more than expected).

Fields of papers citing papers by Daniel Burch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Burch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Burch. The network helps show where Daniel Burch may publish in the future.

Co-authorship network of co-authors of Daniel Burch

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Burch. A scholar is included among the top collaborators of Daniel Burch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Burch. Daniel Burch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shiovitz, Thomas, Earle Bain, David J. McCann, et al.. (2015). Mitigating the Effects of Nonadherence in Clinical Trials. The Journal of Clinical Pharmacology. 56(9). 1151–1164. 79 indexed citations
2.
Targum, Steven D., Daniel Burch, Mahnaz Asgharnejad, et al.. (2014). Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patients. European Neuropsychopharmacology. 24(8). 1188–1195. 10 indexed citations
3.
Targum, Steven D., J. Cara Pendergrass, Chelsea Toner, Mahnaz Asgharnejad, & Daniel Burch. (2014). Audio-digital recordings used for independent confirmation of site-based MADRS interview scores. European Neuropsychopharmacology. 24(11). 1760–1766. 10 indexed citations
4.
Burch, Daniel, et al.. (2013). Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI. Clinical Pharmacology in Drug Development. 3(1). 4–12. 2 indexed citations
5.
Dagan, Ron, Samuel E. McLinn, Nazha Abughali, et al.. (2000). Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. The Pediatric Infectious Disease Journal. 19(2). 95–104. 150 indexed citations
6.
7.
Jacobs, Michael R., Ron Dagan, Peter C. Appelbaum, & Daniel Burch. (1998). Prevalence of Antimicrobial-Resistant Pathogens in Middle Ear Fluid: Multinational Study of 917 Children with Acute Otitis Media. Antimicrobial Agents and Chemotherapy. 42(3). 589–595. 169 indexed citations
8.
Behrendt, Carolyn E., et al.. (1998). International variation in the management of infants hospitalized with respiratory syncytial virus. European Journal of Pediatrics. 157(3). 215–220. 155 indexed citations
9.
Hoberman, Alejandro, Jack L. Paradise, Daniel Burch, et al.. (1997). Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin®) for treatment of acute otitis media in children. The Pediatric Infectious Disease Journal. 16(5). 463–470. 119 indexed citations
10.
Hoberman, Alejandro, et al.. (1996). Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. The Pediatric Infectious Disease Journal. 15(10). 955–962. 57 indexed citations
11.
Stratton, Charles W., et al.. (1986). Effect of human serum on inhibition of growth ofStaphylococcus aureus by antimicrobial agents. European Journal of Clinical Microbiology & Infectious Diseases. 5(3). 351–353. 4 indexed citations
12.
Burke, Steven D., et al.. (1980). An efficient and versatile synthesis of β-alkylidene-α,α-disubstituted cyclopentanones. Tetrahedron Letters. 21(14). 1285–1288. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Goehrs Breakdown of academic impact, for papers by P Grob Breakdown of academic impact, for papers by P Davey Breakdown of academic impact, for papers by M. Maya Dutta-Linn Breakdown of academic impact, for papers by Andrew Coco Breakdown of academic impact, for papers by Bryan Knepper Breakdown of academic impact, for papers by Jennifer E Girotto Breakdown of academic impact, for papers by Laurence Caeymaex Breakdown of academic impact, for papers by Sophie E. Katz Breakdown of academic impact, for papers by Viola Korczak
Rankless by CCL
2026